Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: August 11, 2022

Details for New Drug Application (NDA): 018063

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 018063 describes CORGARD, which is a drug marketed by Uswm and is included in one NDA. It is available from two suppliers. Additional details are available on the CORGARD profile page.

The generic ingredient in CORGARD is nadolol. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the nadolol profile page.

Summary for 018063

Tradename:	CORGARD
Applicant:	Uswm
Ingredient:	nadolol
Patents:	0
Formulation / Manufacturing:	see details

Pharmacology for NDA: 018063

Mechanism of Action	Adrenergic beta-Antagonists

Medical Subject Heading (MeSH) Categories for 018063

Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Sympatholytics

Suppliers and Packaging for NDA: 018063

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CORGARD	nadolol	TABLET;ORAL	018063	NDA	US WorldMeds, LLC	27505-100	27505-100-01	100 TABLET in 1 BOTTLE (27505-100-01)
CORGARD	nadolol	TABLET;ORAL	018063	NDA	US WorldMeds, LLC	27505-101	27505-101-01	100 TABLET in 1 BOTTLE (27505-101-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	40MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	80MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	120MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:		RLD:	No

Expired US Patents for NDA 018063

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-002	Approved Prior to Jan 1, 1982	See Plans and Pricing	See Plans and Pricing
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-005	Oct 28, 1986	See Plans and Pricing	See Plans and Pricing
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-001	Approved Prior to Jan 1, 1982	See Plans and Pricing	See Plans and Pricing
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-002	Approved Prior to Jan 1, 1982	See Plans and Pricing	See Plans and Pricing
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-004	Approved Prior to Jan 1, 1982	See Plans and Pricing	See Plans and Pricing
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-001	Approved Prior to Jan 1, 1982	See Plans and Pricing	See Plans and Pricing
Uswm	CORGARD	nadolol	TABLET;ORAL	018063-003	Approved Prior to Jan 1, 1982	See Plans and Pricing	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

Colorcon

Johnson and Johnson

Merck

Moodys

McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.